smithonstocks.com

comp | Expert Financial Analysis and Reporting | Smith on Stocks

Expert Financial Analysis and Reporting. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Aug 13, 2015 • ( 3. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Comments on Agenus, ImmunoCellular, Discovery Laboratories, Neuralstem, Kite and Juno. Illegal Naked Short Selling Appears to Lie at the Heart of an Extensive Stock Manipulation Scheme. Comments...

http://www.smithonstocks.com/

OVERVIEW OF smithonstocks.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR SMITHONSTOCKS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 2.7 out of 5 with 6 reviews

5 star

0

4 star

2

3 star

2

2 star

0

1 star

2

Hey there! Start your review of smithonstocks.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

2.7 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT SMITHONSTOCKS.COM

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599

1.48●●●●2598

SM●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599

1.48●●●●2598

SM●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599

1.48●●●●2598

SM●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2010 December 22
UPDATED: 2013 December 13
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

13

YEARS
5

MONTHS
15

DAYS

NAME SERVERS

1: ns1.sportame.net
2: ns2.sportame.net

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

20

SSL

EXTERNAL LINKS

22

SITE IP

162.211.84.105

LOAD TIME

2.719 sec

SCORE

6.2

PAGE TITLE

comp | Expert Financial Analysis and Reporting | Smith on Stocks | smithonstocks.com Reviews

<META> DESCRIPTION

Expert Financial Analysis and Reporting. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Aug 13, 2015 • ( 3. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Comments on Agenus, ImmunoCellular, Discovery Laboratories, Neuralstem, Kite and Juno. Illegal Naked Short Selling Appears to Lie at the Heart of an Extensive Stock Manipulation Scheme. Comments...

<META> KEYWORDS

1 cur

2 neuralstem

3 inc.

4 nsi-189 in major depressive disorder

5 nsi-566 stem cells in als

6 celldex therapeutics

7 cldx

8 glembatumumab

9 rintega

10 varilumab

CONTENT

Page content here

KEYWORDS ON PAGE

reports,blog,subscriptions,join now,posted,larry smith,recent reports,recent blogs,laquo;older posts,login »,register »,social feeds,recent posts,recent comments,archives,categories,company commentary,company reports,investment theses,market commentary

SERVER

Apache

POWERED BY

PHP/5.5.22

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

comp | Expert Financial Analysis and Reporting | Smith on Stocks | smithonstocks.com Reviews

https://smithonstocks.com

Expert Financial Analysis and Reporting. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Aug 13, 2015 • ( 3. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Comments on Agenus, ImmunoCellular, Discovery Laboratories, Neuralstem, Kite and Juno. Illegal Naked Short Selling Appears to Lie at the Heart of an Extensive Stock Manipulation Scheme. Comments...

INTERNAL PAGES

smithonstocks.com

1

November, 2014 | Expert Financial Analysis and Reporting | Smith on Stocks

http://smithonstocks.com/2014/11

Expert Financial Analysis and Reporting. Archive for November, 2014. Northwest Biotherapeutics: Putting Recent Clinical Data on DCVax Direct in Perspective (NWBO, Buy, $5.37). Nov 28, 2014 • ( 4. Antares: 2015 Could Be the Breakout Year for the Stock (ATRS, $2.24, Buy). Nov 23, 2014 • ( 13. Northwest Biotherapeutics: Capital Raise of $35 Million could be a Positive Catalyst for the Stock (Buy, $5.14). Nov 20, 2014 • ( 5. Eil Woodford, a highly respected UK portfolio manager has just invested $25 million ...

2

March, 2015 | Expert Financial Analysis and Reporting | Smith on Stocks

http://smithonstocks.com/2015/03

Expert Financial Analysis and Reporting. Archive for March, 2015. Effective Treatment of Hyperkalemia Promises to be a Multi-billion Opportunity. Mar 31, 2015 • ( 2. Northwest Biotherapeutics: Promising New Data Was Just Presented on DCVax-L in Recurrent Glioblastoma Multiforme (NWBO, Buy, $7.29). Mar 27, 2015 • ( 19. Northwest Biotherapeutics: Highlights of the 2014 10-K (NWBO, Buy, $7.81). Mar 18, 2015 • ( 3. Ntroduction Northwest Biotherapeutics just issued their 10-K for 2014 and I would urge everyon...

3

Archives | Expert Financial Analysis and Reporting | Smith on Stocks

http://smithonstocks.com/archives

Expert Financial Analysis and Reporting. Cytokinetics; Amgen and Servier Announce Decision to Move Omecamtiv Mecarbil into Phase 3 (CYTK, Buy, $12.07). Antares; Are Mylan’s Woes A Potential Positive for AB Rated Generic to EpiPen (ATRS, $1.37, Buy). Antares: Comment on Strength in the Stock Price (ATRS, $1.29, Buy). Cytokinetics: Tirasemtiv Completes Phase 3 Enrollment (CYTK, Buy, $11.89). Celldex: Update Based on 2Q, 2016 Conference Call (CLDX, Neutral, $4.45). AMAG Pharmaceuticals: Initiation of Resear...

4

August, 2015 | Expert Financial Analysis and Reporting | Smith on Stocks

http://smithonstocks.com/2015/08

Expert Financial Analysis and Reporting. Archive for August, 2015. Review of SmithOnStocks Recommendations; August 17, 2015. Aug 17, 2015 • ( 6. Urpose of Report I am leaving on vacation and will be back on August 27, 2015; you won’t hear from me until then. As the second quarter conference calls and accompanying updates are almost behind us, I thought I would provide a quick summary of where I stand on the15 companies I cover. These are […]. Aug 13, 2015 • ( 10. Aug 11, 2015 • ( 4. Discovery Laboratorie...

5

February, 2015 | Expert Financial Analysis and Reporting | Smith on Stocks

http://smithonstocks.com/2015/02

Expert Financial Analysis and Reporting. Archive for February, 2015. Cytokinetics: Key Catalysts for 2015 Strongly Support My Buy Recommendation (CYTK, $7.85). Feb 20, 2015 • ( 4. Alimera Sciences: Some Thoughts on the Upcoming US Launch of Iluvien (ALIM, Neutral, $5.29). Feb 18, 2015 • ( 5. Some Observations on Northwest Biotherapeutics (NWBO), Neuralstem (CUR), Cytokinetics (CYTK) and Immuno-Cellular (IMUC) from Their Presentations at BIO CEO. Feb 10, 2015 • ( 16. He BIO CEO Conference is being held in...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

stocksdd.blogspot.com

Stocks DD...: December 2013

http://stocksdd.blogspot.com/2013_12_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Monday, December 23, 2013. Stocks DD Cites Ackman's Q4 Investor Letter Update. Read, understand and consent to the blog's DISCLAIMER here. Before proceeding to read the article. Not much info at all other Herbalife.

stocksdd.blogspot.com

Stocks DD...: October 2014

http://stocksdd.blogspot.com/2014_10_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Wednesday, October 8, 2014. Stocks DD Opines : A ruling in the Banana Republic creates a brouhaha and How will Ball Street Journal editorialize it? Read, understand and consent to the blog's DISCLAIMER here. By no means,...

stocksdd.blogspot.com

Stocks DD...: May 2015

http://stocksdd.blogspot.com/2015_05_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Wednesday, May 13, 2015. Stocks DD Opines: The Shareholder Pledge, Shareholder Day and Words of Ethical Wisdom for Board Members. Read, understand and consent to the blog's DISCLAIMER here. Many companies already do annu...

stocksdd.blogspot.com

Stocks DD...: Stocks DD Opines & Cites: Biosimilars - Arguably a Big, Complex, Niche Business Opportunity of this Decade in Pharma

http://stocksdd.blogspot.com/2015/11/stocks-dd-opines-cites-biosimilars.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Monday, November 23, 2015. Stocks DD Opines and Cites: Biosimilars - Arguably a Big, Complex, Niche Business Opportunity of this Decade in Pharma. Read, understand and consent to the blog's DISCLAIMER. Biosimilars vs Int...

stocksdd.blogspot.com

Stocks DD...: Stocks DD Opines: The Shareholder Pledge, Shareholder Day & Words of Ethical Wisdom for Board Members

http://stocksdd.blogspot.com/2015/05/stocks-dd-opines-ethical-words-of-wisdom.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Wednesday, May 13, 2015. Stocks DD Opines: The Shareholder Pledge, Shareholder Day and Words of Ethical Wisdom for Board Members. Read, understand and consent to the blog's DISCLAIMER here. Many companies already do annu...

stocksdd.blogspot.com

Stocks DD...: June 2014

http://stocksdd.blogspot.com/2014_06_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Tuesday, June 24, 2014. Stocks DD Cites : Valeant's Rebuttal to Allergan's Rebuttal. Read, understand and consent to the blog's DISCLAIMER here. Before proceeding to read the article. Subscribe to: Posts (Atom). By no me...

stocksdd.blogspot.com

Stocks DD...: Stocks DD Cites: 80-Year old Shareholder with significant net worth in FNMA writes letter to FNMA Board

http://stocksdd.blogspot.com/2016/03/80-year-old-shareholder-with.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Friday, March 4, 2016. Stocks DD Cites: 80-Year old Shareholder with significant net worth in FNMA writes letter to FNMA Board. Read, understand and consent to the blog's DISCLAIMER here. JOSHUA J. ANGEL. Follow Stocks D...

stocksdd.blogspot.com

Stocks DD...: April 2015

http://stocksdd.blogspot.com/2015_04_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Sunday, April 26, 2015. Stocks DD Opines: Investor Relations and some Best Practices. Read, understand and consent to the blog's DISCLAIMER. Before proceeding to read the article. What is Investor Relations? 2 Annual att...

stocksdd.blogspot.com

Stocks DD...: March 2016

http://stocksdd.blogspot.com/2016_03_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Friday, March 4, 2016. Stocks DD Cites: 80-Year old Shareholder with significant net worth in FNMA writes letter to FNMA Board. Read, understand and consent to the blog's DISCLAIMER here. JOSHUA J. ANGEL. If you like to ...

stocksdd.blogspot.com

Stocks DD...: November 2015

http://stocksdd.blogspot.com/2015_11_01_archive.html

Read and Consent to Legal Disclaimer- here. Currently covering TARO(long), TSRX CVR(long),APD(long), FNMA(long),MMYT,CEMP,FIATY, AMRN, JCP, MNTA, and BAC.WS.A, HKD, HLF. Shareholders should engage in constructive activism by actively engaging with board to maximize value of their shares. Monday, November 23, 2015. Stocks DD Opines and Cites: Biosimilars - Arguably a Big, Complex, Niche Business Opportunity of this Decade in Pharma. Read, understand and consent to the blog's DISCLAIMER. Biosimilars vs Int...

UPGRADE TO PREMIUM TO VIEW 12 MORE

TOTAL LINKS TO THIS WEBSITE

22

SOCIAL ENGAGEMENT

SmithOnStocks

SmithOnStocks

OTHER SITES

smithonpolitics.blogspot.com

SMITH ON POLITICS

Subscribe to: Posts (Atom). New York, NY, United States. Read more at http:/ www.bigsight.org/nicholas e smith. View my complete profile.

smithonpolitics.wordpress.com

SMITH on POLITICS « The Left is Right. The Right is Wrong.

Who is Nick E. Smith? The Left is Right. The Right is Wrong. Thoughts on Obama-Biden Inauguration. Thoughts on Obama-Biden Inauguration. January 22, 2013 11:49 am. 2 Comments on I’m Back! Thoughts on Obama-Biden Inauguration. I stopped blogging over a year ago after starting work in the New York State legislature. But, on the occasion of the President’s inauguration, I figured there would be no better time than now to start blogging again. But, will his governance match the rhetoric from his speech?

smithonproperty.blogspot.com

Smith on Property Law

Smith on Property Law. Comments on California real property law, including eminent domain, title disputes, and development law. Not intended as legal advice. Wednesday, March 18, 2009. Eminent domain must describe project sufficiently. The Matteoni firm scored an important reform of government's ability to take private property in the case of. City of Stockton v. Marina Towers. The City's resolution of necessity merely stated (with the usual mumbo-jumbo) that the property was needed for redevelopment&#46...

smithonsmiles.blogspot.com

Smith on Smiles

Sunday, August 26, 2012. Welcome Dr. Christine H. Fitzgerald. We are excited to welcome Dr. Christine Halliday Fitzgerald. Dr Fitzgerald joined us in early August 2012. She is a wonderful asset to our team. We hope you will ask to meet her next time you are in our office. Dr Michael A. Smith. Friday, October 8, 2010. A New Way To Look At Your Healthy Mouth. To learn more visit www.greatsouthernsmiles.com. Dr Michael A. Smith. Subscribe to: Posts (Atom). Welcome Dr. Christine H. Fitzgerald.

smithonsoftware.com

Web Page Under Construction

This Site Is Under Construction and Coming Soon. This Domain Is Registered with NameSecure.

smithonstocks.com

comp | Expert Financial Analysis and Reporting | Smith on Stocks

Expert Financial Analysis and Reporting. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Aug 13, 2015 • ( 3. Neuralstem: The 2015 Decline in the Stock is in Contrast to Encouraging ALS Data and an Impressive Pipeline (CUR, Buy, $1.38). Comments on Agenus, ImmunoCellular, Discovery Laboratories, Neuralstem, Kite and Juno. Illegal Naked Short Selling Appears to Lie at the Heart of an Extensive Stock Manipulation Scheme. Comments...

smithonstyle.com

smithonstyle.com - This website is for sale! - smithonstyle Resources and Information.

The domain smithonstyle.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

smithonthecuyahoga.com

Smith on the Cuyahoga

Employers provide challenging, paid internships which are the cornerstone of the summer experience. Summer on the Cuyahoga offers students from participating schools both a wide range of internships that reflect the diversity of Northeast Ohio’s economy, and a unique social and immersion experience into our community. Bull; SOTC ASSISTANT SUMMER PROGRAM COORDINATOR (Intern) Summer on the Cuyahoga. Summer on the Cuyahoga News and Events. Bull; SOTC Recruiting is now closed. A little about sotc. Po box 110...

smithonvoip.com

VoIP Consultant - Smith on VoIP

Citrix Acquires Cloud Phone System Provider Grasshopper. April 8, 2015. The feeding frenzy around Cloud VoIP companies continues and this time it’s not an VoIP industry incumbent at the table. Fresh off the news of Vonage’s acquisition of SimpleSignal for a total of $25 million, SAAS giant Citrix. Announced yesterday they were plucking Grasshopper. A cloud based phone system provider, from the field. Jive Continues it’s Growth Tear With Two More VoIP Acquisitions. January 14, 2015. Both providers were he...

smithonweb.com

The website for smithonweb.com can be found by clicking here. Smithonweb.com is registered through Easily.co.uk - get web site hosting or domain name registration here.

smithonwine.com

alan smith, on wine

Alan smith, on wine. Alan Smith drinks wine, and he wants to share his findings with you. His mission: discover reasonably priced wines that outclass their contemporaries. For as Alan has been known to say, “if all you had to do was buy the most expensive bottle, where would the fun be in that? A wine hobbyist for forty years, Alan Smith lives a robust, superhero-esque existence in Vancouver, Canada. July 28, 2010. Reds: rich and berried. The categories, explained. Go to: categories explained.